Illinois News Joint

JANUARY 30, 2023

The Cannabis Regulation Oversight Office (CROO) today announced the launch of its new website. The new CROO website has been designed to be more user friendly and a better comprehensive resource for recreational and medical cannabis in Illinois. For more Illinois cannabis industry news, visit here.

Media 80

Media Data Agriculture Recreational 80

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. Media Contact: Will Johnson. 646) 421-9523. 201-465-8019.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. What is Artisanal CBD?

Epilepsy 58

Epilepsy Pharmaceutical Patients Sleep 58

Cannabis Law Report

AUGUST 2, 2021

–(BUSINESS WIRE)– #cannabis — PureVita Labs , a 6,800 square-foot facility designed to be the premier cannabis and hemp testing and analytics laboratory in the New England region, has been licensed by the Department of Health to sample and test marijuana for potency and contaminants. WEST WARWICK, R.I.–(BUSINESS

Hemp 105

Hemp Data Cultivation Patients 105

Illinois News Joint

DECEMBER 18, 2023

A month later, the premiere resource for the Illinois cannabis industry was born. News Joint Cannabis Events is the cannabis-friendly events planning and consulting service from Illinois News Joint. News Joint Cannabis Events is the cannabis-friendly events planning and consulting service from Illinois News Joint.

Events 92

Events Media Patients Data 92

Cannabis Law Report

SEPTEMBER 15, 2019

The full media report dated 30 August 2019 can be found at. Medizinisches Cannabis bringt dem Staat Millionen. million tax revenues through cannabis as medicine. According to a media report , the German government took almost 13.3 million euros in tax revenues with medicinal cannabis in 2018. reported. ).

Media 45

Media Medicine Collective Data 45

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. were awarded a Class2 License which permits them to cultivate cannabis with 50,000 square feet of canopy.

Media 52

Media Data Dispensary Access 52

SpeedWeed

MARCH 17, 2021

In the realm of Cannabis M&A activity, Curaleaf’s purchase of the three Arrow Alternative Care (AAC) Dispensaries in Connecticut will not land on any league table or leaderboard for size of deal or industry impact. Deal size aside, we wanted to share what we look at on the data side when a public company or MSO announces a deal.

Media 52

Media Data Dispensary Cultivation 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52

Media CBD Events THC 52

Cannabis Law Report

AUGUST 27, 2021

The Board will further serve as a resource for media, other medical associates and general audiences interested in the science behind psychedelic wellness and treatments. Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Illinois News Joint

MAY 27, 2023

The list of cannabis brands to choose from on dispensary menus seems to be expanding by the day, and even we are losing track. So we created Know Your Brand, an educational series to help readers, followers, and consumers learn more about new and established cannabis brands in Illinois. Kaviar is both.”

Terpenes 80

Terpenes Strains Dispensary Events 80

Cannabis Law Report

JUNE 30, 2021

Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. of patients with major depressive disorder, 92.7% of patients with bipolar disorder, 71% of patients with generalized anxiety disorder, and 97.8% of patients with social anxiety disorder. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

SpeedWeed

MARCH 2, 2021

This southern state has a large population and is embarking upon a limited license program where Georgia’s Access to Medical Cannabis Commission will bestow only six licenses. When we founded Cannabiz Media, our choice was to focus exclusively on cannabis licenses, companies, and contacts. Cannabis Mountain LLC.

Media 52

Media Seed-To-Sale Oil Business 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

SpeedWeed

MARCH 8, 2021

Each year on March 8, we honor this tradition by highlighting the women of Cannabis Conference, an impressive roster of women shattering glass ceilings, making space for themselves and other notable women in the burgeoning cannabis industry. . As we continue to announce speakers for Cannabis Conference (Aug. Theresa Bennett.

Legalization 52

Legalization Dispensary Media Supply Chain 52

Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. Using Cannabis to Quit Opioids. Among the most common reasons patients cited for moving to marijuana were: Better pain management. Many patients preferred cannabis over opioids.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

JULY 9, 2021

The medical use of certain psychedelic drugs and substances remain illegal under Canadian federal law unless discretionary exemptions are granted under the CDSA, while a limited number of other drugs and substances may be prescribed by a health care practitioner to patients under their care. SOURCE Horizons ETFs Management ( Canada ) Inc.

Data 105

Data Clinical Trials Decriminalization Hemp 105

Freedom Leaf

JANUARY 4, 2018

“Our goal is to bring awareness of emerging innovation and opportunities to the East Coast regarding cannabis technology.” Cofounder, Jade Insights and Cannabis Tech Group, New York, N.Y. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., DNA variations or polymorphisms) in patients with African ancestry. Poster Number: INFO37. Poster Number: PO1326.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

SpeedWeed

APRIL 21, 2021

You cannot read a cannabis industry newsletter these days without seeing articles that hype the future impact of New York, New Jersey, Virginia, and New Mexico adult use programs. Georgia has a low THC oil program that is challenging for patients and their families. The oil has to be sourced out of state and patients needed a waiver.

Programs 52

Programs Dispensary Oil Cultivation 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

SEPTEMBER 20, 2021

KWC and KIC have been focused on opening locations in Secondary cities with considerable demand, in an effort to provide access to the most patients. Adding KWC will ensure our existing patients and many more in the future will receive the best medical treatment and care.

Treatment 52

Treatment Media Research and Development Patients 52

SpeedWeed

MARCH 8, 2021

Each year on March 8, we honor this tradition by highlighting the women of Cannabis Conference, an impressive roster of women shattering glass ceilings, making space for themselves and other notable women in the burgeoning cannabis industry. . As we continue to announce speakers for Cannabis Conference (Aug. Theresa Bennett.

Dispensary 40

Dispensary Media Supply Chain Hemp 40

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. Four in five Americans (80% ) voiced their support for a program that would make it easier to detect legal vs. illegal cannabis products.

Safety 52

Safety Research and Development Compliance Compliance 52

CannaMD

MAY 19, 2020

In a working draft of research prepared by Canadian scientists, study authors claim that their findings are “crucial for the future analysis of the effects of medical cannabis on COVID-19.” And then something interesting happened: Serendipitously, we noted that cannabis may also affect ACE2. COVID-19 Basics: ACE2.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Cannabis Law Report

JULY 29, 2021

HPPD is most commonly caused by LSD and Mushrooms, but also can be caused by MDMA, Cannabis, and even SSRIs. There have been various individual studies of the condition, but the Ehave study could be the largest patient study to date. Media Inquiries: Gabe Rodriguez. Forward-Looking Statement Disclaimer. Contact: Ehave Inc.

Research and Development 105

Research and Development Conditions Data Patients 105